Crystalline anti-hTNFalpha antibodies
AssigneeAbbott Biotechnology Ltd.
InventorsDavid W. Borhani, Wolfgang Fraunhofer, Hans-Juergen Krause, Anette Koenigsdorfer, Gerhard Winter, Stefan Gottschalk
Life of this patent
Estimating the term…
Abstract
The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.
Claims44
A batch crystallization method for crystallizing an anti-hTNFalpha antibody, comprising the steps of:
- (a) providing an aqueous solution of said antibody in admixture with an inorganic phosphate salt as crystallization agent;
- and
- (b) incubating said aqueous crystallization mixture until crystals of said antibody are formed.
A crystal of an anti-hTNFalpha antibody, with the proviso that said antibody is not INFLIXIMAB.
Dependencies are inferred from the claim text.